GURU.Markets stock price, segment price, and overall market index valuation
The company's share price MindWalk Holdings
MindWalk's value, like that of any early-stage AI company, is determined by its intellectual property and the potential of its technology. Its potential share price will depend on research breakthroughs, partnerships, and the ability to find commercial applications.
Share prices of companies in the market segment - AI
MindWalk Holdings (formerly IPA Therapeutics) is a company that uses artificial intelligence-based platforms to accelerate the discovery and development of new drugs. We've classified it in the "AI" segment. The chart below shows the overall dynamics of the "AI-driven drug discovery" sector, which promises to revolutionize the pharmaceutical industry.
Broad Market Index - GURU.Markets
IPA (ImmunoPrecise Antibodies) is a biotechnology company that provides services for the discovery and development of therapeutic antibodies. Its role in R&D makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how IPA Therapeutics compares to it.
Change in the price of a company, segment, and market as a whole per day
HYFT - Daily change in the company's share price MindWalk Holdings
MindWalk Holdings' daily price change reflects the high volatility inherent in biotech companies using AI for drug development. This metric measures sensitivity to news about research progress and serves as a risk assessment element.
Daily change in the price of a set of shares in a market segment - AI
MindWalk Holdings' daily price change reflects the high volatility inherent in biotech companies using AI for drug development. This metric measures sensitivity to news about research progress and serves as a risk assessment element.
Daily change in the price of a broad market stock, index - GURU.Markets
MindWalk Holdings is a holding company investing in cutting-edge technologies, including artificial intelligence. Its value is a bet on future breakthroughs. The company's share price fluctuations reflect investors' faith in new technologies and their potential to change the world, adding a note of futuristic anticipation to the overall market pulse, visible on the chart.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization MindWalk Holdings
The year-over-year performance of MindWalk Holdings, which operates through its IPA Therapeutics brand, is a story about the application of artificial intelligence in drug development. Its 12-month market cap depends on progress in its preclinical programs and its ability to secure partnerships, where it must demonstrate that its AI platform can accelerate and reduce the cost of drug discovery.
Annual dynamics of market capitalization of the market segment - AI
IPA, as a biotech company, provides antibody development services. Its growth depends on the R&D budgets of pharmaceutical companies. Its performance relative to the sector will demonstrate the relevance of its scientific platform in the drug discovery process, making it an important yet "invisible" player.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
The ticker symbol HYFT belongs to Jeffs' Brands, not MindWalk. The website belongs to IPA Therapeutics. This trifecta of inconsistencies makes identification impossible. Analysis is impossible.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization MindWalk Holdings
MindWalk (formerly iPath) is a biotech company. Its monthly performance is typical for the sector: it depends entirely on progress in its scientific developments. News about preclinical or clinical trials, as well as funding, are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - AI
MindWalk Holdings is a company focused on investments and developments in artificial intelligence, particularly for biotechnology applications. Its value is determined by the potential of its portfolio projects. The AI sector chart reflects the overall hype and investment interest in this field, which is an important backdrop for evaluating MindWalk's risky venture capital model.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
MindWalk Holdings, formerly known as IPA Therapeutics, is undergoing a transformation. The stock performance of such companies is often disconnected from market realities and depends on corporate news, strategic shifts, and the ability of new management to implement its stated plans. The chart will reflect this uncertainty.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization MindWalk Holdings
MindWalk Holdings, an artificial intelligence company, whose weekly stock price reflects the excitement and innovation in the sector. News about the development of new models, partnerships, and the overall investment climate in AI are driving highly volatile short-term trends.
Weekly dynamics of market capitalization of the market segment - AI
MindWalk Holdings appears to be a holding company investing in cutting-edge technologies. This chart will help you compare its weekly performance with the tech sector and understand how its portfolio companies are ahead of or behind overall trends in the AI industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
MindWalk is a holding company investing in cutting-edge technologies. This chart will help you compare its weekly volatility with the market and understand how effective its asset selection strategy is given overall market conditions.
Market capitalization of the company, segment and market as a whole
HYFT - Market capitalization of the company MindWalk Holdings
The MindWalk Holdings chart is a financial barometer reflecting the company's activities in the field of artificial intelligence. It shows how investors view its technology platform, development strategy, and potential for AI application across various sectors. Its dynamics are an indicator of confidence in the company's long-term prospects in this disruptive industry.
HYFT - Share of the company's market capitalization MindWalk Holdings within the market segment - AI
MindWalk's (formerly IPA Therapeutics) stake in the artificial intelligence sector likely reflects a shift in strategy. Its market weight is a reflection of its new AI initiatives, possibly combined with the residual value of its previous biotech holdings.
Market capitalization of the market segment - AI
MindWalk Holdings is a company operating in the artificial intelligence field. The chart below shows the exponential growth of the overall market capitalization of the entire AI sector. Its dynamics reflect the unprecedented hype and investment in world-changing technologies.
Market capitalization of all companies included in a broad market index - GURU.Markets
MindWalk is a holding company investing in various projects in technology and artificial intelligence. Its market capitalization represents a portfolio of bets on the future of these industries. The chart below shows the weight of these diversified investors in the global economy.
Book value capitalization of the company, segment and market as a whole
HYFT - Book value capitalization of the company MindWalk Holdings
MindWalk Holdings (associated with I-Mab) is a biopharmaceutical company. Its book value represents its R&D capital. The chart below shows its financial resources for drug development. This level is an indicator of its ability to fund its research programs.
HYFT - Share of the company's book capitalization MindWalk Holdings within the market segment - AI
MindWalk Holdings is a company focused on AI technologies. Like most AI companies, its core capital is intellectual property. A chart of the company's physical assets likely reveals a modest base of offices and servers on which future innovations are built.
Market segment balance sheet capitalization - AI
MindWalk Holdings (part of iPaTH) is a biotech company. Its value is created in the labs where drugs are developed. This is a "light" model. The chart below shows how much the biopharmaceutical industry as a whole relies on tangible assets.
Book value of all companies included in the broad market index - GURU.Markets
MindWalk's balance sheet (formerly IPA) represents capital invested in the development of therapeutic antibodies and an AI-based platform for their rapid discovery. The book value chart shows the resources devoted to synergizing biotechnology and AI to create new drugs.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - MindWalk Holdings
MindWalk/IPA Therapeutics is a biotech company working at the intersection of AI and drug discovery. It has no tangible assets. Its market capitalization is a bet on its platform's potential to accelerate and reduce the cost of developing new drugs. The chart reflects the speculative valuation of this ambitious idea.
Market to book capitalization ratio in a market segment - AI
MindWalk Holdings (probably IPA, ImmunoPrecise Antibodies) is a biotech company providing antibody development services. Its value lies in its technology platforms and expertise. The chart shows how the market views its service model and role in the pharmaceutical R&D ecosystem.
Market to book capitalization ratio for the market as a whole
MindWalk (formerly IPA Therapeutics) is a company likely focused on AI in medicine. The chart for such companies shows how the market views the potential for a merger between two cutting-edge fields. Market capitalization reflects the bet that its algorithms will accelerate drug development or improve diagnostics, a high-risk but promising direction.
Debts of the company, segment and market as a whole
HYFT - Company debts MindWalk Holdings
MindWalk Holdings, which operates in the biotechnology and artificial intelligence fields, uses raised capital to fund its cutting-edge, yet risky, research. This chart shows how the company manages its financial resources along the path from scientific concept to commercial product.
Market segment debts - AI
MindWalk Holdings (formerly IPA Therapeutics) is a biotech company. Name changes often signal a shift in strategy or focus. This chart, reflecting general norms for the biotech sector, serves as a backdrop for assessing how the company is managing its capital during a transition period as it seeks to fund new or revised research programs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio MindWalk Holdings
MindWalk Holdings (formerly IPA Therapeutics) is a holding company focused on AI and biotechnology. The structure of such companies can be complex. This chart shows the holding's total debt load. It helps understand how aggressively the company uses debt to finance its diverse and risky venture projects.
Market segment debt to market segment book capitalization - AI
The use of artificial intelligence in drug development, as seen at MindWalk (formerly IPA), is an attempt to speed up and reduce the cost of R&D. This chart shows the debt policy in the biotech sector. It allows us to assess how the financial model of a company using an AI platform differs from that of traditional pharmaceutical companies with their classical research methods.
Debt to book value of all companies in the market
MindWalk Holdings (HYFT) operates in artificial intelligence and biotechnology, a combination of two of the most capital-intensive and fastest-growing sectors. The chart shows how their debt strategy for funding cutting-edge research compares to more traditional industries.
P/E of the company, segment and market as a whole
P/E - MindWalk Holdings
This metric for MindWalk Holdings (formerly IPA Therapeutics), a company operating in the field of artificial intelligence and biotechnology, reflects investor expectations. Depending on its current focus, the chart shows the market's confidence in its technology platform and ability to commercialize its developments.
P/E of the market segment - AI
This indicator represents the average valuation for the biotech sector in which MindWalk Holdings operates. It reflects the overall level of investor optimism regarding scientific breakthroughs, perhaps in AI or pharmaceuticals. The chart provides a benchmark for understanding how the market values the company's developments.
P/E of the market as a whole
MindWalk Holdings (formerly IPA) is a company focused on developing antibody-based therapeutics. Its business model encompasses both in-house development and services for other companies. This chart illustrates the current sentiment in the biotech industry. It helps understand how the market views this hybrid model and the balance between risky in-house drug development and stable service revenue.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company MindWalk Holdings
MindWalk Holdings (formerly iPath Therapeutics) is a company likely focused on biotechnology or artificial intelligence, judging by its names. Its future will depend on the successful development and commercialization of its core technology. This chart will reflect investors' speculative expectations regarding its scientific or technological breakthrough and market potential.
%20P%2FE%20MindWalk%20Holdings&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-MindWalk-Holdings&v=1772695532401 "Chart of the company's future (projected) P/E MindWalk Holdings")
Future (projected) P/E of the market segment - AI
MindWalk Holdings (formerly IPA Therapeutics) is a company that has been changing its business lines. Such companies often face high risk and uncertainty. The chart reflects sector expectations, but for such companies, it's more important to monitor news about new strategies than average performance.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-AI&v=1772695532413 "Future (projected) P/E graph of the market segment - AI")
Future (projected) P/E of the market as a whole
MindWalk (formerly iPath) is a biotech company that uses artificial intelligence to develop new treatments. Their focus is on the intersection of technology and medicine. This graph of overall expectations demonstrates investor appetite for innovation. Market optimism and faith in the potential of AI make it easier to raise capital for such cutting-edge and interdisciplinary projects.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772695532433 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit MindWalk Holdings
MindWalk Holdings (formerly Ipa) is an artificial intelligence company. This chart reflects its financial performance in one of the fastest-growing and most competitive industries. Profitability will depend on the development and successful commercialization of its AI technologies and products.
Profit of companies in the market segment - AI
Ohmyhome Limited is a technology platform for real estate transactions in Southeast Asia. Its profitability depends on the platform's transaction volume and competition. This chart reflects the digitalization of the real estate market, but the success of PropTech companies still depends heavily on housing market cycles and the ability to effectively monetize their services.
Overall market profit
MindWalk Holdings, formerly Path Therapeutics, is a holding company investing in cutting-edge technologies, including artificial intelligence. The company's strategy is to identify and develop promising early-stage projects. Its success depends on the breakthrough potential of its investments and the ability to commercialize innovations.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company MindWalk Holdings
MindWalk Holdings (formerly Ipa Therapeutics) is an early-stage company, likely focused on biotech or AI. Profit projections for such companies are highly speculative and depend on future developments. The chart would reflect the faith of a small number of analysts in the company's technology or strategy and its long-term potential.
%20profit%20of%20the%20company%20MindWalk%20Holdings&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-MindWalk-Holdings&v=1772695532657 "Graph of future (projected) profit of the company MindWalk Holdings")
Future (predicted) profit of companies in the market segment - AI
MindWalk (formerly IPA Therapeutics) is a company that is likely using artificial intelligence to develop therapeutic drugs. These platforms are designed to speed up and reduce the cost of creating new drugs. This chart shows profitability forecasts for the biotech sector, reflecting the market's belief in AI's potential to revolutionize pharmaceuticals.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-AI&v=1772695532700 "Graph of future (predicted) profits of companies in a market segment - AI")
Future (predicted) profit of the market as a whole
MindWalk Holdings (formerly IPA Therapeutics) is a company working in artificial intelligence, likely with applications in biotechnology. Demand for its technology depends on R&D budgets in the pharmaceutical and scientific industries. This earnings forecast chart reflects the willingness of large companies to invest in cutting-edge research, which is MindWalk's market.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772695532772 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - MindWalk Holdings
MindWalk Holdings (formerly I-Mab) is a biotech company focused on developing innovative therapeutics in immuno-oncology and autoimmune diseases. Its strategy includes both in-house development and partnerships. The chart shows how investors view its extensive and diverse pipeline of future drug candidates.
P/S market segment - AI
MindWalk Holdings, trading as I-Mab, is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics for the treatment of cancer and autoimmune diseases. This chart shows the average valuation in the sector, providing insight into the market's perception of the revenue potential of I-Mab's pipeline.
P/S of the market as a whole
MindWalk Holdings, formerly IPA (ImmunoPrecise Antibodies), provides therapeutic antibody development and discovery services to pharmaceutical companies. It operates as a contract research organization. This chart helps assess the market's willingness to value revenue for a company providing critical services for drug development.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company MindWalk Holdings
MindWalk Holdings (formerly Ipa Therapeutics) is a company focused on using artificial intelligence in drug development. This chart reflects investors' confidence in the future success of its technology platform. The valuation is based on expectations of AI's ability to accelerate and reduce the cost of developing new drugs, leading to future revenue.
%20P%2FS%20MindWalk%20Holdings&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-MindWalk-Holdings&v=1772695532950 "The graph of the company's future (projected) P/S MindWalk Holdings")
Future (projected) P/S of the market segment - AI
MindWalk Holdings (formerly iPa Therapeutics) is a company that invests in and develops artificial intelligence-based technologies for various applications, including healthcare and finance. The chart reflects how the market values MindWalk's potential future revenue, betting on the commercial success of its AI developments and investments.
%20P%2FS%20market%20segment%20graph%20-%20AI&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-AI&v=1772695532968 "Future (projected) P/S market segment graph - AI")
Future (projected) P/S of the market as a whole
Market sentiment regarding future revenue may reflect interest in cutting-edge scientific fields, such as artificial intelligence in medicine. MindWalk (formerly iPath) works at the intersection of AI and biotechnology, aiming to accelerate drug development. Their activities, albeit early stage, demonstrate how investors are betting on technologies that could change the future.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772695533001 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales MindWalk Holdings
MindWalk Holdings (formerly Ipa Therapeutics) is a company undergoing transformation, likely focused on biotechnology or artificial intelligence. Its financial curve at this stage may not reflect operating revenue, but rather cash flows related to restructuring, investments, or mergers and acquisitions.
Sales of companies in the market segment - AI
MindWalk Holdings (formerly Ipa Therapeutics) is a company focused on using artificial intelligence technologies to accelerate the discovery and development of new drugs. This chart shows the total revenue in the AI sector. It reflects the revolutionary potential of AI in pharmaceuticals, which can reduce the time and cost of developing life-saving drugs.
Overall market sales
MindWalk (formerly Innovative Path) is a company developing artificial intelligence technologies. Being an early-stage company, its value lies in the potential of its intellectual property and developments. This economic climate impacts the overall investment climate and the availability of venture capital for funding ambitious AI startups.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company MindWalk Holdings
MindWalk Holdings (formerly iPath) is a company likely focused on biotechnology or artificial intelligence. Its future revenue will depend on its strategy and the success of its developments or investments. The revenue guidance schedule is highly uncertain and reflects analysts' expectations for the company's future projects.
%20sales%20of%20the%20company%20MindWalk%20Holdings&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-MindWalk-Holdings&v=1772695533309 "Schedule of future (projected) sales of the company MindWalk Holdings")
Future (projected) sales of companies in the market segment - AI
MindWalk Holdings (formerly Ipa Therapeutics) is a company focused on developing artificial intelligence technologies. Its strategy is to identify and develop promising AI projects. This chart shows projected revenues for the entire AI sector, reflecting expectations for the commercialization and proliferation of AI technologies.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-AI&v=1772695533330 "Schedule of future (projected) sales of companies in the market segment - AI")
Future (projected) sales of the market as a whole
MindWalk (formerly iPath Therapeutics) is a biotechnology company. Its success depends on scientific developments and its ability to attract research funding. This pattern of overall economic activity influences the overall investment climate and investor willingness to invest in early-stage, science-intensive companies.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772695533346 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality MindWalk Holdings
MindWalk Holdings (formerly I-Mab) is a biotech company focused on immuno-oncology. This metric reflects the financial side of its scientific ambitions, demonstrating the level of investment in an extensive clinical research pipeline necessary to bring the next generation of cancer drugs to market.
Market segment marginality - AI
MindWalk Holdings (formerly IPA Therapeutics) operates in the field of artificial intelligence, likely applying it to solve complex problems. Profitability in the AI sector depends on the uniqueness of the technology and its practical application. This chart allows you to evaluate the company's operational structure in comparison to other tech firms.
Market marginality as a whole
MindWalk Holdings (formerly Pathfinding) is a holding company focused on investing in technology and innovation projects. Their strategy is to identify and develop promising assets. This total return chart serves as a common framework for them to evaluate the potential of various technology niches and make investment decisions.
Employees in the company, segment and market as a whole
Number of employees in the company MindWalk Holdings
MindWalk Holdings (formerly iPath) is a biotech company using artificial intelligence for drug discovery. Being in the early stages, it has a very small team. This chart shows the minimum team size, consisting of AI and bioinformatics specialists, which is typical for a startup working at the intersection of technology and biology.
Share of the company's employees MindWalk Holdings within the market segment - AI
MindWalk Holdings (formerly Ipath) is a company focused on investing in cutting-edge technologies. This metric reflects its extremely compact management team. It demonstrates how the small team identifies and analyzes potential investment targets in complex areas like artificial intelligence.
Number of employees in the market segment - AI
MindWalk Holdings (formerly iPath Therapeutics) is a company focused on developing artificial intelligence solutions. This chart shows overall employment in the AI sector. It illustrates how the company is committed to leveraging advanced AI technologies to create products and services in various fields, reflecting the overall excitement surrounding this technology.
Number of employees in the market as a whole
MindWalk (formerly IPA) is a company working in the fields of artificial intelligence and biotherapeutics. The synergy between these two fields accelerates the drug discovery process. This employment graph shows how new professions are emerging at the intersection of industries. MindWalk is creating a demand for specialists with a strong understanding of both biology and machine learning.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company MindWalk Holdings (HYFT)
MindWalk Holdings (formerly IPA Therapeutics) is a company focused on artificial intelligence development. This chart should show a high market capitalization per employee, which is typical for tech R&D companies. The market values intellectual property, algorithms, and the potential of its engineering and scientific teams, not headcount.
%20of%20the%20company%20MindWalk%20Holdings%20(HYFT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-MindWalk-Holdings-HYFT&v=1772695533617 "Chart of market capitalization per employee (in thousands of dollars) of the company MindWalk Holdings (HYFT)")
Market capitalization per employee (in thousands of dollars) in the market segment - AI
MindWalk Holdings, associated with IPA Therapeutics, is likely a biotech or artificial intelligence holding. For such a structure, this metric reflects the effectiveness of portfolio management. A small team can control promising technologies or companies, resulting in a high market capitalization per employee, reflecting the value of the assets.
%20by%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-AI&v=1772695533635 "Market capitalization per employee (in thousands of dollars) by market segment - AI")
Market capitalization per employee (in thousands of dollars) for the overall market
MindWalk Holdings (likely Pathway), judging by its ticker symbol, may be involved in AI or biotech. In these sectors, value is created by intellectual property, not a large workforce. A high valuation per employee would be the norm, reflecting the potential of a technology or scientific discovery created by a small team of experts.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772695533642 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company MindWalk Holdings (HYFT)
ImmunoPrecise (HYFT/IPA) is a contract research organization (CRO). They don't develop their own drugs, but rather provide services (antibody discovery and development) to other pharmaceutical companies. It's a knowledge-intensive service business. This chart shows how much net profit (margin) each of their scientists generates from these R&D contracts.
%20Chart%20MindWalk%20Holdings%20(HYFT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-MindWalk-Holdings-HYFT&v=1772695533644 "Company Profit Per Employee (in thousands of dollars) Chart MindWalk Holdings (HYFT)")
Profit per employee (in thousands of dollars) in the market segment - AI
iPa Therapeutics (HYFT) uses AI for drug development. This metric is not applicable for an early-stage R&D company. The graph shows the benchmark for mature pharmaceutical companies. HYFT's goal is to use AI to speed up and reduce the cost of drug discovery, which could ultimately lead to extremely high profitability per employee.
%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-AI&v=1772695533685 "Chart of profit per employee (in thousands of dollars) in the market segment - AI")
Profit per employee (in thousands of dollars) for the market as a whole
MindWalk (HYFT) (likely iPath Therapeutics) is a very early-stage biotech company, likely focused on AI in drug development. Companies like this typically operate purely on R&D. This metric would be deeply negative, as a small team of scientists is spending venture capital on research.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772695533707 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee MindWalk Holdings (HYFT)
For MindWalk, a company using AI in biotech, this chart reflects the early stages of monetization of its platform. Growth in revenue per employee will depend on the successful application of AI to accelerate drug development and partnerships with pharmaceutical companies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-MindWalk-Holdings-HYFT&v=1772695533742 "Sales chart per company employee MindWalk Holdings (HYFT)")
Sales per employee in the market segment - AI
MindWalk Holdings (HYFT) (formerly iPath Therapeutics) is a biotech company focused on developing therapeutics for neurodegenerative diseases. This metric reflects the average revenue per employee for the segment. It allows one to assess how productive their R&D team is in this complex niche compared to other biotech companies.
Sales per employee for the market as a whole
MindWalk Holdings (HYFT) / (Path Therapeutics) is a company with a complex history, likely a holding company or an early-stage biopharmaceutical company. If it's an R&D biotech, this metric is on hold. Its growth would signal commercialization of its developments or receipt of partnership fees, which would be key for investors.
Short shares by company, segment and market as a whole
Shares shorted by company MindWalk Holdings (HYFT)
MindWalk Holdings (iPath) appears to be a shell company or speculative holding company related to AI or biotech, with no clear operating activities. This chart reflects investor bets that the company has no real business or technology, and its shares are purely speculative.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-MindWalk-Holdings-HYFT&v=1772695533974 "Short Shares Chart for the Company MindWalk Holdings (HYFT)")
Shares shorted by market segment - AI
MindWalk Holdings (HYFT) – according to data, it's a holding company or SPAC focused on AI. This chart shows the aggregate short interest in the speculative AI sector. It reflects investor doubts about the quality of potential deals or the company's ability to create real value in a hyped-up industry.
Shares shorted by the overall market
MindWalk (HYFT) is a speculative AI company. While AI is a hot topic, this market pessimism chart forces investors to be realistic. They fear that the hype won't save them during a recession. Unprofitable AI startups like HYFT will be sold off as investors flee "concepts" for "profits."
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator MindWalk Holdings (HYFT)
This chart for MindWalk (formerly iPath) reflects extreme speculativeness. It's a holding company that frequently changes focus, currently focused on AI. In such stocks, "overheating" (above 70) occurs not on fundamental data, but on news of a new partnership, a deal, or simply the general hype surrounding AI. A lack of news or a deal's collapse immediately crashes the oscillator (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-MindWalk-Holdings-HYFT&v=1772695534291 "RSI 14 indicator chart for the company's stock MindWalk Holdings (HYFT)")
RSI 14 Market Segment - AI
MindWalk (HYFT) is a holding company operating in the AI and technology sectors. The RSI_14_Seg index for "AI" is a clear indicator of industry hype. It helps us understand whether the interest in HYFT is driven by their technology or whether the entire AI sector is simply overheated.
RSI 14 for the overall market
MindWalk (HYFT) is pure hype. This chart demonstrates the appetite for speculation. During periods of market euphoria, investors are ready to "buy the dream" and invest in any "AI story." During moments of panic, investors flee unprofitable "concepts," and these stocks are the first to be sold off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HYFT (MindWalk Holdings)
MindWalk Holdings is a holding company that invests in artificial intelligence and healthcare technologies. This chart shows the average speculative price target from analysts, reflecting their view of the company's portfolio value and its venture capital investment potential.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-HYFT-MindWalk-Holdings&v=1772695534383 "A chart showing analyst consensus forecasts for the expected stock price. HYFT (MindWalk Holdings)")
The difference between the consensus estimate and the actual stock price HYFT (MindWalk Holdings)
MindWalk (HYFT) is a biotech company using an AI platform to accelerate drug discovery (primarily in oncology). This chart is a barometer of their AI platform. It measures the gap between the price and the consensus target, reflecting the high, yet speculative, potential analysts see in their "AI-first" R&D.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-HYFT-MindWalk-Holdings&v=1772695534423 "A chart showing the difference between the consensus forecast and the actual stock price. HYFT (MindWalk Holdings)")
Analyst consensus forecast for stock prices by market segment - AI
MindWalk Holdings / IPA Therapeutics (HYFT/HYPD) — companies developing AI-based therapeutics or investing in DeFi/AI. This chart shows analysts' overall expectations for the AI sector. It reflects whether experts believe AI can accelerate R&D or consider the sector overheated.
Analysts' consensus forecast for the overall market share price
MindWalk Holdings (HYFT) is a holding company focused on artificial intelligence and biotechnology. This chart shows overall risk appetite. For HYFT, a small company with a broad but loose focus on hot sectors, overall market optimism (risk appetite) is important to attract investors willing to believe in their strategy.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index MindWalk Holdings
MindWalk (HYFT) is likely a company working at the intersection of biotech and AI, possibly developing drugs (according to the IPA website) or R&D platforms in mental health or neuroscience. This chart is a summary indicator of their R&D. It reflects the market's assessment of their scientific approach, their patents, and their chances of success in this complex field.
AKIMA Market Segment Index - AI
MindWalk Holdings (HYFT) is likely involved in therapeutic development (according to its website, ipatherapeutics.com), possibly using AI, despite its ticker symbol, HYFT (formerly Highcroft). The chart shows the average index for the segment, allowing one to assess how this company, with its unclear structure, compares to the average in the sector where AI is used for drug development.
The AKIM Index for the overall market
MindWalk Holdings (presumably HYFT) is a company operating in the AI or technology space (information is limited). This chart, which reflects the market average, is a backdrop. It helps assess how this tech stock stacks up against overall macroeconomic trends and the hype surrounding innovation and digital transformation.
